IP Verse

Adjuvanted Glucans

Patent No. EP2227248 (titled "Adjuvanted Glucans") was filed by GlaxoSmithKline Biologicals SA on Nov 26, 2008. The application was issued on Jan 31, 2018.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ABIVAXMar 10, 2015LAVOIX

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2227248

GLAXOSMITHKLINE BIOLOGICALS SA
Application Number
EP08862064A
Filing Date
Nov 26, 2008
Status
Patent Maintained As Amended
Dec 29, 2017
Publication Date
Jan 31, 2018
External Links
Slate, Register , Google Patents